Novel Immunomodulatory Treatment Against Hypertriglyceridemia
A high efficacy, long-term immunomodulatory treatment with no side effects reduces plasma triglycerides by 50%
Published: 20th May 2021

Patents
- PATENT APPLICATION: EP20 217536.0
IP Status
- Patent application submitted